MoneyShow contributor John McCamant issues short sale recommendations for three stocks in the gene-editing biotech space. The editor of The Medical Technology Stock Letter talks about recent news and repeats a Strong Buy rating for one gene-editing pla…
The most fundamental way in which the industry creates value is by discovering and manufacturing innovative medicines that help people live longer, healthier, more productive lives.
Pfizer confirmed that time has run out for raising prices without blow-back. The renewed attention to drug price hikes means business as usual has ended and two questions loom large for Pharma. Is talk of regulation of drug prices next and who will ne…
Pfizer, one of the world’s largest drug companies, reversed price hikes it had taken on dozens of medicines last week after a phone call between the company’s chief executive, President Donald Trump, and the Secretary of Health and Human Services, Alex…
If you look hard to find people who have atrial fibrillation you will find atrial fibrillation. But a new study offers no evidence whatsoever that the new diagnosis improves outcomes, though it does find that the diagnosis leads to increased use of dru…
Whistleblowing is a powerful tool in the fight against wrongdoing. The process is hazardous and fraught with perils, both for the accuser and the accused with long-lasting consequences.
If you were to ask the CEOs of Pfizer, Merck, Lilly, etc., they would be more than happy to drop the “user fees” and have Congress fully fund the FDA via other funding mechanisms.
The high price of pharmaceuticals have become a constant topic of discussion in the U.S. although very few consumers ever pay out-of-pocket prices thanks to insurance. But in the case that an individual had to pay list price, the following 10 drugs are…
The biopharmaceutical industry isn’t perfect. But let’s stop with the nonsense that the industry invents diseases. It’s not true.
An experimental gene therapy appeared to dramatically increase the production of a muscle-making protein in three young boys with Duchenne muscular dystrophy, a deadly and irreversible disease, according to results being presented by the drugmaker Sare…
